1. Home
  2. ALTI vs MNPR Comparison

ALTI vs MNPR Comparison

Compare ALTI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$3.73

Market Cap

394.0M

Sector

Finance

ML Signal

N/A

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$57.60

Market Cap

372.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
MNPR
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
372.9M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
ALTI
MNPR
Price
$3.73
$57.60
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$101.42
AVG Volume (30 Days)
94.9K
150.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.11
N/A
EPS
N/A
N/A
Revenue
$206,935,000.00
N/A
Revenue This Year
$19.78
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$26.06
52 Week High
$5.45
$105.00

Technical Indicators

Market Signals
Indicator
ALTI
MNPR
Relative Strength Index (RSI) 28.49 48.74
Support Level $3.31 $56.15
Resistance Level $4.39 $61.30
Average True Range (ATR) 0.25 3.36
MACD -0.08 0.83
Stochastic Oscillator 10.06 65.33

Price Performance

Historical Comparison
ALTI
MNPR

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: